Related Experiment Video
Updated: Jan 21, 2026

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
Published on: May 10, 2022
Current challenges in sudden cardiac death prevention
Domenico Corrado1, Alessandro Zorzi2, Emilio Vanoli3,4
1Department of Cardiac Thoracic, Vascular Sciences and Public Health, University of Padova, Via N. Giustiniani 2, 35121, Padova, Italy. domenico.corrado@unipd.it.
Insights
Sudden cardiac death (SCD) prevention in heart failure relies on implantable cardioverter defibrillators (ICDs), but current selection criteria lack specificity. This review explores SCD mechanisms and improved risk stratification strategies for better prevention.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Heart Failure Management
Background:
- Ischemic heart disease and non-ischemic dilated cardiomyopathy are leading causes of sudden cardiac death (SCD).
- Implantable cardioverter defibrillator (ICD) therapy is the sole proven effective strategy for SCD prevention in high-risk patients.
- Current guidelines for ICD selection based on ejection fraction and heart failure class lack sensitivity and specificity.
Purpose of the Study:
- To review the mechanisms underlying SCD in heart failure patients.
- To discuss current and novel risk stratification methods for SCD.
- To outline comprehensive strategies for SCD prevention in clinical practice.
Main Methods:
- Literature review of mechanisms, risk stratification, and prevention strategies for SCD.
- Analysis of current guidelines and their limitations in identifying high-risk individuals.
- Synthesis of evidence on therapeutic interventions including ICDs and pharmacotherapy.
Main Results:
- SCD mechanisms in heart failure are complex and multifactorial.
- Existing risk stratification parameters for ICD implantation are insufficient.
- A multi-faceted approach to SCD prevention is crucial.
Conclusions:
- Optimizing heart failure therapy and avoiding triggers are foundational.
- ICD therapy remains critical but requires refined patient selection.
- Integrated strategies including early resuscitation and public access defibrillation enhance overall SCD prevention efforts.
Abstract:
Ischemic heart disease and non-ischemic dilated cardiomyopathy are the most common causes of arrhythmic sudden cardiac death (SCD). Implantable cardioverter defibrillator (ICD) therapy is the only strategy that proved to be effective in preventing SCD in high-risk individuals while the role of antiarrhythmic drugs is limited to symptoms relief. Current guidelines recommend selecting candidates to ICD implantation based on etiology, symptoms of heart failure (NYHA class), and severely depressed left ventricular ejection fraction, but these parameters are neither sensitive nor specific. The review addresses the mechanisms of SCD in patients with heart failure of either ischemic or non-ischemic etiology, risk stratification, and strategies for prevention of SCD in the clinical practice (including optimization of heart failure therapy, avoidance of triggering factors, antiarrhythmic drugs, ICD therapy, early resuscitation, and public access defibrillators).
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Electrical Current
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

